Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Merck & Co (NY:MRK)

100.30 +1.29 (+1.30%)
Official Closing Price Updated: 7:00 PM EST, Dec 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 11,810,806
Open 98.96
Bid (Size) 99.75 (1,000)
Ask (Size) 100.30 (200)
Prev. Close 99.01
Today's Range 98.31 - 100.66
52wk Range 73.31 - 105.84
Shares Outstanding 2,531,374,696
Dividend Yield 3.23%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Here Are 2 Affordable Healthcare Stocks to Buy Heading Into 2026 ↗
They could grow into their valuation over the next few years. 
Via The Motley Fool
Topics Intellectual Property
News headline image
Great Rotation: Tech Exodus Fuels Dow's Record Run While Nasdaq Struggles
As of December 12, 2025, the financial markets are witnessing a significant "Great Rotation," a pronounced shift of capital from high-growth technology and Artificial Intelligence (AI) stocks to more... 
Via MarketMinute
Topics Artificial Intelligence Bonds Economy

Performance

YTD
+1.1%
+1.1%
1 Month
+9.7%
+9.7%
3 Month
+21.1%
+21.1%
6 Month
+22.8%
+22.8%
1 Year
-0.9%
-0.9%

More News

Read More
News headline image
The Green Revolution in Silicon: Semiconductor Manufacturing Embraces Sustainability
Via TokenRing AI
Topics Artificial Intelligence Climate Change Economy
News headline image
Merck Receives Positive EU CHMP Opinion for Expanded Use of WINREVAIR™ (sotatercept) in Adults with Pulmonary Arterial Hypertension (PAH, WHO* Group 1 Pulmonary Hypertension)
From Merck & Co., Inc.
Via Business Wire
News headline image
2 Mega-Cap Stocks with Exciting Potential and 1 We Ignore
Via StockStory
News headline image
Dividend Stocks for 2026: Where to Invest as the Market Cools ↗
Via MarketBeat
News headline image
2 Pharmaceutical Stocks to Buy at a Discount ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Healthcare Sector Falters: S&P 500's Biggest Loser Amid Broader Market Caution
Via MarketMinute
Topics ETFs Economy Intellectual Property
News headline image
Explore the top gainers and losers within the S&P500 index in today's session. ↗
Via Chartmill
News headline image
Here's 1 Major Catalyst Behind Merck Stock's Recent 3.8% Bump ↗
Via The Motley Fool
News headline image
1 Major Factor Behind the Healthcare Sector's Recent Surge ↗
Via The Motley Fool
News headline image
Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones? ↗
Via The Motley Fool
Topics Economy Stocks
News headline image
Merck's Stock is Suddenly Soaring, but Is the Struggling Healthcare Giant a Buy? ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Do These 3 Healthcare Stocks Need a Checkup? ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Trading Near Its 52-Week Low, Is Summit Therapeutics a Good Stock to Buy Right Now? ↗
Via The Motley Fool
News headline image
Is This Pharmaceutical Giant a Buy After a Major Acquisition? ↗
Via The Motley Fool
Topics Death
News headline image
These Are the 3 Hottest Stocks in the S&P 500 Heading Into the New Year. Should You Invest in Them? ↗
Via The Motley Fool
Topics Stocks
News headline image
With Netflix's 10-for-1 Stock Split Complete, Here Are 3 Growth Stocks to Buy in December That Could Issue Stock Splits in 2026 ↗
Via The Motley Fool
Topics Artificial Intelligence Economy Stocks
News headline image
FDA Conditionally Approves Merck Animal Health's EXZOLT™ CATTLE-CA1 for the Prevention and Treatment of New World Screwworm (Cochliomyia hominivorax) Larvae (myiasis)
From Merck & Co., Inc.
Via Business Wire
News headline image
3 Top ETFs I Plan to Pile Into in December to Boost My Passive Income in 2026 ↗
Via The Motley Fool
Topics ETFs Stocks
News headline image
Global Prescription Drug Market Poised for Trillion-Dollar Surge by 2035
Via MarketMinute
Topics Artificial Intelligence Death Intellectual Property
News headline image
Wall Street's Tentative Triumph: Dow, S&P 500, Nasdaq Edge Higher Amidst Shifting Tides
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
Chronic Rare Diseases in an Aging America: Why HyBryte and Federal Policy Matter Now
Via Investor Brand Network
Topics Government
News headline image
Chronic Rare Diseases in an Aging America: Why HyBryte and Federal Policy Matter Now
From BioMedWire
Via GlobeNewswire
News headline image
2 Monster Stocks in the Making to Buy and Hold ↗
Via The Motley Fool

Frequently Asked Questions

Is Merck & Co publicly traded?
Yes, Merck & Co is publicly traded.
What exchange does Merck & Co trade on?
Merck & Co trades on the New York Stock Exchange
What is the ticker symbol for Merck & Co?
The ticker symbol for Merck & Co is MRK on the New York Stock Exchange
What is the current price of Merck & Co?
The current price of Merck & Co is 100.30
When was Merck & Co last traded?
The last trade of Merck & Co was at 12/12/25 07:00 PM ET
What is the market capitalization of Merck & Co?
The market capitalization of Merck & Co is 253.90B
How many shares of Merck & Co are outstanding?
Merck & Co has 254B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.